Your browser doesn't support javascript.
loading
A radioiodinated FR-ß-targeted tracer with improved pharmacokinetics through modification with an albumin binder for imaging of macrophages in AS and NAFL.
Wen, Xuejun; Shi, Changrong; Yang, Liu; Zeng, Xinying; Lin, Xiaoru; Huang, Jinxiong; Li, Yesen; Zhuang, Rongqiang; Zhu, Haibo; Guo, Zhide; Zhang, Xianzhong.
Affiliation
  • Wen X; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China.
  • Shi C; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China.
  • Yang L; State Key Laboratory for Bioactive Substances and Functions of Natural Medicines, Beijing, Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
  • Zeng X; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China.
  • Lin X; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China.
  • Huang J; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, 361003, China.
  • Li Y; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, 361003, China.
  • Zhuang R; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China.
  • Zhu H; State Key Laboratory for Bioactive Substances and Functions of Natural Medicines, Beijing, Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
  • Guo Z; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China. gzd666888@xmu.edu.cn.
  • Zhang X; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China. zhangxzh@xmu.edu.cn.
Eur J Nucl Med Mol Imaging ; 49(2): 503-516, 2022 01.
Article in En | MEDLINE | ID: mdl-34155537

Full text: 1 Database: MEDLINE Main subject: Tomography, Emission-Computed, Single-Photon / Radiopharmaceuticals / Atherosclerosis / Non-alcoholic Fatty Liver Disease Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2022 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Tomography, Emission-Computed, Single-Photon / Radiopharmaceuticals / Atherosclerosis / Non-alcoholic Fatty Liver Disease Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2022 Type: Article Affiliation country: China